Stockscreener 앱 받기
555.47
0.44%
-2.45
시장 영업 전:
554.50
-0.97
-0.17%
Thermo Fisher Scientific Inc (TMO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-30 | 2023-12-31 | 2023-09-30 | 2023-07-01 | 2023-04-01 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
4.97%
10,345.00
|
10,886.00 | 10,574.00 | 10,687.00 | 10,710.00 |
Operating Expenses
|
3.88%
8,682.00
|
9,032.00 | 8,710.00 | 9,109.00 | 9,147.00 |
| Interest Income/Expense |
6.92%
363.00
|
390.00 | 359.00 | 326.00 | 300.00 |
| Benefits Costs and Expenses |
4.26%
8,756.00
|
9,146.00 | 8,809.00 | 9,257.00 | 9,347.00 |
| Costs And Expenses |
3.88%
8,682.00
|
9,032.00 | 8,710.00 | 9,109.00 | 9,147.00 |
| Operating Income/Loss |
10.30%
1,663.00
|
1,854.00 | 1,864.00 | 1,578.00 | 1,563.00 |
| Income/Loss Before Equity Method Investments |
8.68%
1,589.00
|
1,740.00 | 1,765.00 | 1,430.00 | 1,363.00 |
| Income/Loss From Equity Method Investments |
2,400%
23.00
|
-1.00 | -17.00 | -16.00 | -25.00 |
| Income/Loss From Continuing Operations Before Tax |
8.68%
1,589.00
|
1,740.00 | 1,765.00 | 1,430.00 | 1,363.00 |
| Income Tax Expense/Benefit |
111.28%
281.00
|
133.00 | 53.00 | 52.00 | 46.00 |
| Income/Loss From Continuing Operations After Tax |
18.61%
1,308.00
|
1,607.00 | 1,712.00 | 1,378.00 | 1,317.00 |
|
Net Income/Loss
|
17.12%
1,331.00
|
1,606.00 | 1,695.00 | 1,362.00 | 1,292.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
116.67%
4.00
|
-24.00 | -20.00 | 1.00 | 3.00 |
| Basic Average Shares |
382.00
|
- | 386.00 | 386.00 | 386.00 |
| Diluted Average Shares |
384.00
|
- | 388.00 | 388.00 | 388.00 |
| Basic Earnings Per Share |
17.58%
3.47
|
4.21 | 4.44 | 3.53 | 3.34 |
| Diluted Earnings Per Share |
17.62%
3.46
|
4.20 | 4.42 | 3.51 | 3.32 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.23%
2.03%
자본화:
|
볼륨(24시간):